Mitteldorf et al. [164] suggested that PD-L1+ tumor microenvironment (TME) cells induce apoptosis in PD-L1+ tumor-infiltrating lymphocytes, and, therefore, direct inhibition of TME cells, particularly myeloid-derived suppressor cells, could be a promising treatment option. The gene discussed is CD274; the disease is neoplasm.